Literature DB >> 8125397

Gut ischaemia.

U Haglund1.   

Abstract

Intestinal mucosal injury that results from local ischaemia can be detected by early increases in gut permeability, followed by later morphological, histological, and biochemical abnormalities. Local adaptive mechanisms (for example increased oxygen extraction) can cope with reductions in blood flow of up to 50%, as may occur during episodes of septic shock or cardiac tamponade. Why then does hypoxic injury develop? The peculiar vascular anatomy of the villi allows for oxygen short circuiting to occur at their base, when blood flow is low. Although overall oxygen extraction efficiency may be high, regional hypoxia at the villus tip may, paradoxically occur. The severity of reperfusion injury depends on the duration of preceding hypoxia. Free radical generation through the hypoxanthine xanthine oxidase system is important in mediating cellular damage. In addition, luminal aggressive factors (for example, pancreatic proteases) may cause mucosal damage, as suggested by earlier studies. More recent studies in pigs suggests that pancreatic duct ligation merely delays, but does not prevent development of gut reperfusion injury. Enteral nutrition should benefit patients with the ischaemic intestine because in comparison with total parental nutrition, it stimulates regional blood flow, and attenuates mucosal injury. There are no randomised trials to verify this, but use of tonometry to monitor local ischaemia may help resolve the issue.

Entities:  

Mesh:

Year:  1994        PMID: 8125397      PMCID: PMC1378153          DOI: 10.1136/gut.35.1_suppl.s73

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

Review 1.  Oxygen-free radicals (OFR) and circulatory shock.

Authors:  U Haglund; B Gerdin
Journal:  Circ Shock       Date:  1991-08

2.  Regeneration of small bowel mucosa after intestinal ischemia.

Authors:  P O Park; U Haglund
Journal:  Crit Care Med       Date:  1992-01       Impact factor: 7.598

3.  Extravascular shunting of oxygen in the small intestine of the cat.

Authors:  M Kampp; O Lundgren; N J Nilsson
Journal:  Acta Physiol Scand       Date:  1968-04

4.  Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal.

Authors:  C J Chiu; A H McArdle; R Brown; H J Scott; F N Gurd
Journal:  Arch Surg       Date:  1970-10

5.  Validation of tonometric measurement of gut intramural pH during endotoxemia and mesenteric occlusion in pigs.

Authors:  J B Antonsson; C C Boyle; K L Kruithoff; H L Wang; E Sacristan; H R Rothschild; M P Fink
Journal:  Am J Physiol       Date:  1990-10

6.  The intestinal mucosal lesions in shock. I. Studies on the pathogenesis.

Authors:  U Haglund; T Abe; C Ahrén; I Braide; O Lundgren
Journal:  Eur Surg Res       Date:  1976       Impact factor: 1.745

7.  Intestinal tissue PO2 and microvascular responses during glucose exposure.

Authors:  H G Bohlen
Journal:  Am J Physiol       Date:  1980-02

8.  Early gut ischemia in experimental fecal peritonitis.

Authors:  I Rasmussen; U Haglund
Journal:  Circ Shock       Date:  1992-09

9.  Splanchnic oxygen consumption in septic and hemorrhagic shock.

Authors:  D Arvidsson; I Rasmussen; P Almqvist; F Niklasson; U Haglund
Journal:  Surgery       Date:  1991-02       Impact factor: 3.982

10.  Superoxide radicals in feline intestinal ischemia.

Authors:  D N Granger; G Rutili; J M McCord
Journal:  Gastroenterology       Date:  1981-07       Impact factor: 22.682

View more
  25 in total

Review 1.  [Small-volume resuscitation for hypovolemic shock. Concept, experimental and clinical results].

Authors:  U Kreimeier; F Christ; L Frey; O Habler; M Thiel; M Welte; B Zwissler; K Peter
Journal:  Anaesthesist       Date:  1997-04       Impact factor: 1.041

2.  Carbon monoxide liberated from CO-releasing molecule (CORM-2) attenuates ischemia/reperfusion (I/R)-induced inflammation in the small intestine.

Authors:  Kazuhiro Katada; Aurelia Bihari; Shinjiro Mizuguchi; Norimasa Yoshida; Toshikazu Yoshikawa; Douglas D Fraser; Richard F Potter; Gediminas Cepinskas
Journal:  Inflammation       Date:  2010-04       Impact factor: 4.092

3.  Plasma D (-)-lactate as a new marker for diagnosis of acute intestinal injury following ischemia-reperfusion.

Authors:  Y M Yao; Y Yu; Y Wu; L R Lu; Z Y Sheng
Journal:  World J Gastroenterol       Date:  1997-12-15       Impact factor: 5.742

4.  Carbon dioxide transport in rats with acute pancreatitis.

Authors:  X Wang; R Andersson; P Kruse; I Ihse
Journal:  Int J Pancreatol       Date:  1996-04

5.  Role of changes in tissular nucleotides on the development of apoptosis during ischemia/reperfusion in rat small bowel.

Authors:  Meritxell Genescà; Anna Sola; Rosa Miquel; Felip Pi; Carme Xaus; Vicente Alfaro; Georgina Hotter
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 6.  Gastrointestinal symptoms during exercise. The effect of fluid supplementation.

Authors:  H P Peters; L M Akkermans; E Bol; W L Mosterd
Journal:  Sports Med       Date:  1995-08       Impact factor: 11.136

7.  Intestinal epithelial cell-derived μ-opioid signaling protects against ischemia reperfusion injury through PI3K signaling.

Authors:  Jason R Goldsmith; Ernesto Perez-Chanona; Prem N Yadav; Jennifer Whistler; Bryan Roth; Christian Jobin
Journal:  Am J Pathol       Date:  2013-01-02       Impact factor: 4.307

8.  A statin-based inhibitor of lymphocyte function antigen-1 protects against ischemia/reperfusion-induced leukocyte adhesion in the colon.

Authors:  Min Xiu Wan; Rene Schramm; Daniel Klintman; Karl Welzenbach; Gabriele Weitz-Schmidt; Henrik Thorlacius
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

Review 9.  Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury.

Authors:  Emily Archer Slone; Sherry D Fleming
Journal:  Clin Immunol       Date:  2014-05-09       Impact factor: 3.969

10.  Comparative protection against rat intestinal reperfusion injury by a new inhibitor of sPLA2, COX-1 and COX-2 selective inhibitors, and an LTC4 receptor antagonist.

Authors:  Thiruma V Arumugam; Naomi Arnold; Lavinia M Proctor; Michelle Newman; Robert C Reid; Karl A Hansford; David P Fairlie; Ian A Shiels; Stephen M Taylor
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.